A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 495.98
C 32.96
GOOG 607.45
BAC 8.09
RIMM 15.59

Recently Added

CPIC 1.12
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.75

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.12
NBTH 12.50
IDVC 0.35
8.33 -0.26 (-3.06%) ISIS

Click Here to Receive Instant E-mail and RSS Alerts


Trade ISIS now with

Stock Details

Last Trade:8.33 Change:-0.26 (-3.06%) Prev Close:8.59 Open: 8.50 Days Range:8.33 – 8.56 52 Week Range: 6.25 - 9.61 Volume:112831 P/E: N/A
EPS:-0.79





Recent Blog Posts

Blog Posts on 02/09/12 at 5:37pm
Illumina, Roche And Fairness
Blog Posts on 02/09/12 at 3:14pm
Sanofi's Balanced Model Looks Undervalued
Blog Posts on 01/22/12 at 2:21pm
Biogen Idec Turns A Mess Into A Double Win
Blog Posts on 01/20/12 at 5:16am
16 Healthcare Stocks With High Cash Relative To Expenses
Blog Posts on 01/13/12 at 7:28pm
Keeping An Eye On Isis
Blog Posts on 01/12/12 at 2:34pm
Life Technologies Could Open Doors For Pharmaceuticals
Blog Posts on 01/12/12 at 9:58am
16 Healthcare Stocks Deeply Discounted From Target Price
Blog Posts on 01/11/12 at 10:21am
Euphoria From Inhibitex Acquisition Spreads To Other Firms
Blog Posts on 01/06/12 at 6:01am
Healthcare And Technology Stocks Experiencing Heavy And Unusual Insider Selling In December
Blog Posts on 01/05/12 at 4:34pm
Isis Pharmaceuticals CEO Hosts Analyst Day (Transcript)
Blog Posts on 12/29/11 at 1:21pm
Alnylam Looks Nearly Left For Dead
Blog Posts on 12/28/11 at 3:15pm
Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks
Blog Posts on 12/21/11 at 11:15am
Tuesday's Noteworthy Insider Buys And Sells
Blog Posts on 12/21/11 at 12:13am
Marc Lichtenfeld Grades His 2011 Picks
Blog Posts on 12/15/11 at 5:20pm
ISIS's Development Update Conference
Blog Posts on 12/13/11 at 3:24pm
Biotechs To Benefit From Strategy Shift By Big Pharma
Blog Posts on 12/12/11 at 3:02pm
Lower R&D Budgets For Big Pharma Creating A Brighter Future For The Right Biotechs
Blog Posts on 12/07/11 at 3:07pm
3 Biotech Stocks You Should Sell Before 2012
Blog Posts on 12/06/11 at 1:43pm
Alnylam's Drug Technologies Could Be Revolutionary
Blog Posts on 11/23/11 at 4:19pm
20 Healthcare Stocks Deeply Undervalued By Target Price
Blog Posts on 11/07/11 at 9:55pm
Isis Pharmaceuticals CEO Discusses Q3 2011 Results - Earnings Call Transcript
Blog Posts on 09/27/11 at 2:59pm
Beat Up 'Biotechs' To Buy: Part 3
Blog Posts on 05/10/11 at 1:56pm
Rebound Ideas: 7 Oversold Stocks With Sufficient Cash to Cover Operating Expenses
Blog Posts on 05/09/11 at 9:23am
Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector
Blog Posts on 05/05/11 at 6:32pm
Isis Pharmaceuticals' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Blog Posts on 04/05/11 at 2:12pm
Isis Pharmaceuticals: A Lot Riding on Safety of New Drug
Blog Posts on 03/21/11 at 10:41am
China Biotech in Review: U.S. Charges 4 China API Makers With Price-Fixing
Blog Posts on 03/01/11 at 1:35am
Top 30 Most Undervalued, Underperforming Stocks
Blog Posts on 02/28/11 at 8:44pm
Isis Pharmaceuticals CEO Discusses Q4 2010 Results - Earnings Call Transcript
Blog Posts on 02/28/11 at 6:32pm
Battered but Unbroken Biotechs